China (Mainland)
Factory supply 99% FG-4592 CAS 808118-40-3 Roxadustat CAS NO.808118-40-3
- FOB Price: USD: 100.00-100.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
99% purity(1-10)Gram
- Product Details
Keywords
- fg-4592
- fg 4592
- fg4592
Quick Details
- ProName: Factory supply 99% FG-4592 CAS 808118-...
- CasNo: 808118-40-3
- Molecular Formula: C19h16n2o5
- Appearance: powder
- Application: Pharmaceutical intermediate
- DeliveryTime: 12-15 days
- PackAge: Foil Bag, According to Client's Requir...
- Port: SHANGHAI
- ProductionCapacity: 1 Metric Ton/Day
- Purity: 99%
- Storage: store in cool and dry place
- Transportation: FedEx DHL EMS or by Sea
- LimitNum: 1 Gram
- Moisture Content: <0.1%
- Impurity: <0.1%
- Standard: GMP
Superiority
1, High quality with competitive price:
1) Standard:BP/USP/EP/Enterprise standard
2) All Purity≥99%
3) We are manufacturer and can provide high quality products with factory price.
2, Fast and safe delivery
1) Parcel can be sent out in 24 hours after payment.Tracking number available
2) Secure and discreet shipment.Various transportation methods for your choice.
3) Customs pass rate ≥99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe,
and we have stock in there for transferring.
3,We have clients throughout the world.
1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire.
2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility.
14) High quality,competitive price,fast delivery ,first-class service gain the trust and praise from the customers.
Details
What is Roxadustat
Roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), promotes coordinated erythropoiesis through increasing endogenous erythropoietin, improving iron availability, and reducing hepcidin. Administration of roxadustat has been shown to increase red blood cell production while maintaining plasma erythropoietin levels within or near normal physiologic range in multiple subpopulations of CKD patients, including in the presence of inflammation, and without a need for supplemental intravenous iron.
Roxadustat for treatment of anemia associated with chronic kidney disease (CKD)
